Vyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic therapies, today announced a strategic collaboration with Novartis to discover and develop in ...
VANCOUVER, BC / ACCESSWIRE / November 20, 2024 / Arras Minerals Corp. (TSXV:ARK) ("Arras" or "the Company") is pleased to provide an update on the ongoing exploration program across 1,736 sq km of lic ...